Preventing HIV-1 Infection in Women using Oral Pre-Exposure Prophylaxis: A Meta-analysis of Current Evidence.
暂无分享,去创建一个
Brett Hanscom | Peter B Gilbert | Elizabeth R Brown | Holly E Janes | Ying Huang | S. Hammer | P. Guarino | P. Gilbert | H. Janes | D. Donnell | Y. Chen | E. Brown | Scott M Hammer | B. Hanscom | Peter D Guarino | Ying Qing Chen | Deborah J Donnell | Ying Huang
[1] James Y. Dai,et al. Tenofovir-based preexposure prophylaxis for HIV infection among African women. , 2015, The New England journal of medicine.
[2] Alex J. Sutton,et al. Methods for Meta-Analysis in Medical Research , 2000 .
[3] S. P. Akpabio. World Health Organisation , 1983, British Dental Journal.
[4] C. Hendrix,et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial , 2013, The Lancet.
[5] Katrien Fransen,et al. Preexposure prophylaxis for HIV infection among African women. , 2012, The New England journal of medicine.
[6] John T Brooks,et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. , 2012, The New England journal of medicine.
[7] Myron S. Cohen,et al. Penetration of Tenofovir and Emtricitabine in Mucosal Tissues: Implications for Prevention of HIV-1 Transmission , 2011, Science Translational Medicine.
[8] James D. Campbell,et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. , 2012, The New England journal of medicine.